Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

Using vitamin supplements containing vitamin K
History of metabolic gastrointestinal diseases
Subjects presenting chronic degenerative and/or inflammatory diseases
Receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters (salicylates, antibiotics)
Subjects receiving corticosteroid
Use of anticoagulants
History of soy allergy
Have an unstable medical condition, such as having a life expectancy of less than 6 months in the judgment of the investigator
Known sensitivity, intolerance, or other adverse response to study drugs which would prevent compliance with study medication
Subjects who have participated in a clinical study more recently than one month before the current study

Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients